{"url_path":"/sec/lnai/8-k/2026-05-20/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1527728/0001731122-26-000759-index.html","accession_number":"0001731122-26-000759","cik":"0001527728","ticker":"LNAI","issuer_name":"Lunai Bioworks Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1527728/0001731122-26-000759-index.html","primary_entity_key":"0001527728","primary_entity_name":"Lunai Bioworks Inc."},"word_count":143,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n \n\nOn May 20, 2026, Lunai Bioworks, Inc. (the “**Company**”)\nissued a press release announcing that it intends to effect a reverse stock split of its issued and outstanding common stock, par value\n$0.0001 per share (the “Common Stock”), at a ratio of 1-for-8 (the “**Reverse Stock Split**”). The Reverse\nStock Split is expected to become effective at 12:01 a.m. Eastern Time on May 22, 2026, and the Company’s Common Stock is expected\nto begin trading on a split-adjusted basis on The Nasdaq Capital Market at the opening of trading on May 22, 2026, under the existing\ntrading symbol “LNAI.”\n\n \n\nThe Company’s Common Stock will trade under\na new CUSIP number, 29350E302 following the effectiveness of the Reverse Stock Split.\n\n \n\nA copy of the press release is filed herewith as Exhibit\n99.1 and incorporated into this Item 8.01 by reference."}